Sergey Vladimirovich Korenev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sergey Vladimirovich Korenev has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Pavel Olegovich Rumiantsev
My Medical Center LLC
4 shared publications - Andrei Gennadievich Goncharov
Immanuel Kant Baltic Federal University
2 shared publications - Igor Vladimirovich Reshetov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2 shared publications - Olga S. Chukhacheva
Endocrinology Research Centre
2 shared publications - Vladimir V. Rafalskiy
Immanuel Kant Baltic Federal University
2 shared publications - Yu. S. Romanko
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia; Academy of Postgraduate Education, FSCC of FMBA of Russia
2 shared publications
Latest Publications
- Open Access
- 20 December 2024
- Published by Publishing House OKI in Real-World Data & Evidence
- Vol. 4 (3) , 22-32
Real-world data for monitoring antimicrobial resistance to urinary tract infection pathogens
Relevance. The main treatment option for urinary tract infections is antimicrobials, which are selected empirically accord ing to local epidemiologic data. In recent years, a new source of data on antimicrobial resistance, which is based on real-world data (RWD) analysis.Objective. To study the distribution and structure of antimicrobial resistance of urinary infection pathogens in the Kalinin grad region according to RWD.Methods. The results of bacteriological studies on urine samples collected from inhabitants of the Kaliningrad region, which were performed in the INVITRO laboratory, were analyzed. The total number of bacteriologic studies in 2020 was 2251, in 2021–2765, in 2022–2544 and in 2023–2373 samples. Urine samples were collected from the outpatient clinic.Results. The study population was predominantly female (80.0 % to 89.9 %). The suspected causative agent was detected in 26.8 % — 29.3 % of patients. The most frequently isolated pathogen was E. coli (58.7 %–63.1 %). Other bacteria of the order Enterobacterales were isolated much less frequently: Klebsiella pneumoniae (6.4 %–9.7 %), Enterobacter spp. (0.9 %–2.4 %), Proteus spp. (0.3 %–2.9 %), and Pseudomonas aeruginosa (0.7 %–3.7 %). Among Gram-positive bacteria, Enterococci (6.3 %–7.8 %), Streptococcus agalactiae (1.6 %–3.6 %), and Staphylococcus saprophyticus (1.4 %–2.8 %) were most frequently isolated. Growth of resistance to almost all antimicrobial agents was noted. At the same time, fosfomycin (2.9 % of strains are resistant), nitrofurantoin (4.3 %), and amikacin (4.0 %) remain the most active E. coli-resistant drugs.Conclusion. The use of RWD to assess local antimicrobial resistance can be a valuable source of information, reflecting the true picture of antimicrobial resistance in a certain region and complementing the available information provided by other methods.
- 20 December 2024
- Published by Publishing House OKI in Real-World Data & Evidence
- Vol. 4 (3) , 22-32
Open AccessReal-world data for monitoring antimicrobial resistance to urinary tract infection pathogens
Relevance. The main treatment option for urinary tract infections is antimicrobials, which are selected empirically accord ing to local epidemiologic data. In recent years, a new source of data on antimicrobial resistance, which is based on real-world data (RWD) analysis.Objective. To study the distribution and structure of antimicrobial resistance of urinary infection pathogens in the Kalinin grad region according to RWD.Methods. The results of bacteriological studies on urine samples collected from inhabitants of the Kaliningrad region, which were performed in the INVITRO laboratory, were analyzed. The total number of bacteriologic studies in 2020 was 2251, in 2021–2765, in 2022–2544 and in 2023–2373 samples. Urine samples were collected from the outpatient clinic.Results. The study population was predominantly female (80.0 % to 89.9 %). The suspected causative agent was detected in 26.8 % — 29.3 % of patients. The most frequently isolated pathogen was E. coli (58.7 %–63.1 %). Other bacteria of the order Enterobacterales were isolated much less frequently: Klebsiella pneumoniae (6.4 %–9.7 %), Enterobacter spp. (0.9 %–2.4 %), Proteus spp. (0.3 %–2.9 %), and Pseudomonas aeruginosa (0.7 %–3.7 %). Among Gram-positive bacteria, Enterococci (6.3 %–7.8 %), Streptococcus agalactiae (1.6 %–3.6 %), and Staphylococcus saprophyticus (1.4 %–2.8 %) were most frequently isolated. Growth of resistance to almost all antimicrobial agents was noted. At the same time, fosfomycin (2.9 % of strains are resistant), nitrofurantoin (4.3 %), and amikacin (4.0 %) remain the most active E. coli-resistant drugs.Conclusion. The use of RWD to assess local antimicrobial resistance can be a valuable source of information, reflecting the true picture of antimicrobial resistance in a certain region and complementing the available information provided by other methods.
- Open Access
- 15 December 2023
- Published by Publishing House ABV Press in Russian Journal of Child Neurology
- Vol. 18 (4) , 26-35
Modeling neurophysiological and psychomotor relevant criteria in children with motor dysfunction
Background. Cerebral palsy is the most common cause of childhood disability among diseases of the nervous system, the prevalence of which averages 2.5 cases per 1,000 children.Aim. To identify relevant indicators in relation to the prediction of delayed rates of neuropsychic development in children and the formation of cerebral palsy in children 5–8 years old using mathematical modeling.Materials and methods. The study included 100 patients aged 5–8 years: 79 patients with neurological disorders and deviations in psycho-speech development, 21 patients – comparison group. The examination of children in both groups included: analysis of the child’s life history, analysis of psychomotor development in the first year of life, analysis of morbidity in the first year of life, assessment of psychomotor development at the time of the study, electroneuromyography using stimulation and superficial electroneuromyography, as well as ultrasound examination of the lower leg muscles with assessment of the functional state and muscle density using fibroscan.For statistical processing of the obtained data, descriptive statistics were performed. Determination of the statistical significance of indicators was carried out using the Kolmogorov–Smirnov test for continuously distributed values and Fisher’s exact test for discrete values. One-hot coding was used to represent categorical features. The analysis of the obtained data was carried out using a Python program using the pandas, numpy, scikit-learn, and boruta libraries.Results and conclusion. For children with deviations in neuropsychic development, significant early diagnostic markers are parameters of psychomotor development and neurological status (age when the child began to hold his head, decreased strength of the flexors of the foot and hip, level of walking) and instrumental examination (ultrasound of muscles thighs, electroneuromyography) – changes in the density and parameters of electrical excitability of muscles, which can serve as an early diagnostic sign of the development of motor dysfunction and an indicator for the formation of a trajectory of rehabilitation therapy.
- 15 December 2023
- Published by Publishing House ABV Press in Russian Journal of Child Neurology
- Vol. 18 (4) , 26-35
Open AccessModeling neurophysiological and psychomotor relevant criteria in children with motor dysfunction
Background. Cerebral palsy is the most common cause of childhood disability among diseases of the nervous system, the prevalence of which averages 2.5 cases per 1,000 children.Aim. To identify relevant indicators in relation to the prediction of delayed rates of neuropsychic development in children and the formation of cerebral palsy in children 5–8 years old using mathematical modeling.Materials and methods. The study included 100 patients aged 5–8 years: 79 patients with neurological disorders and deviations in psycho-speech development, 21 patients – comparison group. The examination of children in both groups included: analysis of the child’s life history, analysis of psychomotor development in the first year of life, analysis of morbidity in the first year of life, assessment of psychomotor development at the time of the study, electroneuromyography using stimulation and superficial electroneuromyography, as well as ultrasound examination of the lower leg muscles with assessment of the functional state and muscle density using fibroscan.For statistical processing of the obtained data, descriptive statistics were performed. Determination of the statistical significance of indicators was carried out using the Kolmogorov–Smirnov test for continuously distributed values and Fisher’s exact test for discrete values. One-hot coding was used to represent categorical features. The analysis of the obtained data was carried out using a Python program using the pandas, numpy, scikit-learn, and boruta libraries.Results and conclusion. For children with deviations in neuropsychic development, significant early diagnostic markers are parameters of psychomotor development and neurological status (age when the child began to hold his head, decreased strength of the flexors of the foot and hip, level of walking) and instrumental examination (ultrasound of muscles thighs, electroneuromyography) – changes in the density and parameters of electrical excitability of muscles, which can serve as an early diagnostic sign of the development of motor dysfunction and an indicator for the formation of a trajectory of rehabilitation therapy.
- Open Access
- 26 September 2023
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 4 (3) , 411-426
Precision low-dose brachytherapy of prostate cancer under PSMA-receptor molecular visualization
Brachytherapy with implantation of micro sources based on isotope 125I is a preferred treatment for localized prostate cancer without signs of germination of the gland capsule and in the absence of signs of metastases (stage cT1-T23aN0M0). Structural imaging methods (ultrasound, computed tomography, and magnetic resonance imaging) do not have high specificity in the differential diagnosis of prostate cancer. Hybrid technologies of radiation imaging (single-photon emission computed tomography/computed tomography, positron emission tomography/computed tomography, and positron emission tomography/magnetic resonance imaging) combine the advantages of high sensitivity of cross-sectional structural imaging methods (computed tomography and magnetic resonance imaging) and high specificity of molecular imaging methods (single-photon emission computed tomography and positron emission tomography) with tumorotropic radiopharmaceuticals. In this original clinical study, based on seven observations of localized prostate cancer (Gleason 67), it was shown that the precision of low-dose brachytherapy using 125I micro sources of localized prostate carcinomas, along with targeted biopsy, can be increased using hybrid methods of PSMA-receptor molecular imaging (single-photon emission computed tomography/ computed tomography, positron emission tomography/ computed tomography). The single-photon emission computed tomography/ computed tomography method is more accessible than positron emission tomography/ computed tomography. Moreover, when coupled with cold kits (HYNIC-PSMA), it allows research within any radioisotope diagnostics laboratory equipped with single-photon emission computed tomography/ computed tomography. The innovative technology of PSMA-navigation biopsy and brachytherapy, under the control of hybrid molecular imaging, can be used in primary and recurrent cases of localized prostate cancer, increases the accuracy and reduces the traumatic nature of procedures, and increases the medical and economic efficiency of low-dose brachytherapy with 125I micro sources. Further research is needed to improve the technology and evaluate its long-term results.
- 26 September 2023
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 4 (3) , 411-426
Open AccessPrecision low-dose brachytherapy of prostate cancer under PSMA-receptor molecular visualization
Brachytherapy with implantation of micro sources based on isotope 125I is a preferred treatment for localized prostate cancer without signs of germination of the gland capsule and in the absence of signs of metastases (stage cT1-T23aN0M0). Structural imaging methods (ultrasound, computed tomography, and magnetic resonance imaging) do not have high specificity in the differential diagnosis of prostate cancer. Hybrid technologies of radiation imaging (single-photon emission computed tomography/computed tomography, positron emission tomography/computed tomography, and positron emission tomography/magnetic resonance imaging) combine the advantages of high sensitivity of cross-sectional structural imaging methods (computed tomography and magnetic resonance imaging) and high specificity of molecular imaging methods (single-photon emission computed tomography and positron emission tomography) with tumorotropic radiopharmaceuticals. In this original clinical study, based on seven observations of localized prostate cancer (Gleason 67), it was shown that the precision of low-dose brachytherapy using 125I micro sources of localized prostate carcinomas, along with targeted biopsy, can be increased using hybrid methods of PSMA-receptor molecular imaging (single-photon emission computed tomography/ computed tomography, positron emission tomography/ computed tomography). The single-photon emission computed tomography/ computed tomography method is more accessible than positron emission tomography/ computed tomography. Moreover, when coupled with cold kits (HYNIC-PSMA), it allows research within any radioisotope diagnostics laboratory equipped with single-photon emission computed tomography/ computed tomography. The innovative technology of PSMA-navigation biopsy and brachytherapy, under the control of hybrid molecular imaging, can be used in primary and recurrent cases of localized prostate cancer, increases the accuracy and reduces the traumatic nature of procedures, and increases the medical and economic efficiency of low-dose brachytherapy with 125I micro sources. Further research is needed to improve the technology and evaluate its long-term results.
- Open Access
- 6 March 2023
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 20 (4) , 421-434
JAK-inhibitors: clinical pharmacology and application perspectives
BACKGROUND: For the last decade, physicians and researchers have been actively developing and investigating a novel targeted synthetic disease-modifying antirheumatic drugs. The application of drugs that affect the JAK-STAT pathway and multiple proinflammatory cytokines certainly has great potential for the treatment of different inflammatory diseases. This review provides articles from the past 10 years describing these small-molecule inhibitors: clinical pharmacology, safety, adverse effects and application. There is a growing body of literature that recognises the importance of JAK inhibitors as attractive pharmacological alternative to biologics. AIM: The article aims to explore clinical pharmacology of JAK inhibitors, safety, drug interactions, comparison with biologic disease-modifying antirheumatic drugs and perspective applications for these drugs. MATERIALS AND METHODS: The research data in this review is drawn from five main sources: PubMed, Scopus, Medline, GoogleScholar, eLibrary. A search was conducted for the period from 2012 to 2022 in Russian and English, by combinations of words: janus kinase inhibitors, disease-modifying antirheumatic drugs, safety, adverse effects, autoimmune diseases, pharmacokinetics, pharmacodynamics. RESULTS: The most important clinically relevant findings were that these small-molecule inhibitors have a main advantages like oral administration, rapid therapeutics effect and less of patients-non-responders to therapy. On the other hand, JAK inhibitors have a classic pharmacokinetics and pharmacodynamics, this allows to study such parameters using standard methods. CONCLUSIONS: In this review, the aim was to assess clinical pharmacology of JAK inhibitors, safety, comparison withbiologic disease-modifying antirheumatic drugs and perspective applications for these drugs. In general, it seems that the safety issues of JAK inhibitors unresolved, in particular the development of thromboembolic complications, infectiousdiseases, and malignancies. This is an important issue for future research.
- 6 March 2023
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 20 (4) , 421-434
Open AccessJAK-inhibitors: clinical pharmacology and application perspectives
BACKGROUND: For the last decade, physicians and researchers have been actively developing and investigating a novel targeted synthetic disease-modifying antirheumatic drugs. The application of drugs that affect the JAK-STAT pathway and multiple proinflammatory cytokines certainly has great potential for the treatment of different inflammatory diseases. This review provides articles from the past 10 years describing these small-molecule inhibitors: clinical pharmacology, safety, adverse effects and application. There is a growing body of literature that recognises the importance of JAK inhibitors as attractive pharmacological alternative to biologics. AIM: The article aims to explore clinical pharmacology of JAK inhibitors, safety, drug interactions, comparison with biologic disease-modifying antirheumatic drugs and perspective applications for these drugs. MATERIALS AND METHODS: The research data in this review is drawn from five main sources: PubMed, Scopus, Medline, GoogleScholar, eLibrary. A search was conducted for the period from 2012 to 2022 in Russian and English, by combinations of words: janus kinase inhibitors, disease-modifying antirheumatic drugs, safety, adverse effects, autoimmune diseases, pharmacokinetics, pharmacodynamics. RESULTS: The most important clinically relevant findings were that these small-molecule inhibitors have a main advantages like oral administration, rapid therapeutics effect and less of patients-non-responders to therapy. On the other hand, JAK inhibitors have a classic pharmacokinetics and pharmacodynamics, this allows to study such parameters using standard methods. CONCLUSIONS: In this review, the aim was to assess clinical pharmacology of JAK inhibitors, safety, comparison withbiologic disease-modifying antirheumatic drugs and perspective applications for these drugs. In general, it seems that the safety issues of JAK inhibitors unresolved, in particular the development of thromboembolic complications, infectiousdiseases, and malignancies. This is an important issue for future research.
- Open Access
- 31 October 2022
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 21 (5) , 149-154
Forms of cell death and targets at photodynamic therapy
The aim of the study is to study the results of the most significant studies on the forms of tumor cell death and targets in photodynamic therapy (PDT). Material and methods. On the problem, we analyzed the Scopus, WoS, MedLine databases and found 31 sources. Results. PDT is an important tool for studying the pathways leading to the complete devitalization of a malignant tumor. Moreover, subcellular targets in pdt are determined by the properties of photosensitizers (PS). Particularly effective targets are lysosomes and mitochondria, including those for class I PS, photofrin. This explains the effectiveness of photofrin, although it has a weak absorption band in the region of 630 nm with a limited penetration depth into tissues. The development of new PSs with subcellular targets of photofrin, but with an absorption band in the long-wavelength region, is becoming very topical. Such FS are ideal for PDT. Second-generation PSS have already been introduced into clinical practice. The effectiveness of PDT with the use of photoditazine was shown. The mechanisms of action and targets of this PS have been established. The latter include the vessel wall, cytoplasmic membranes, and internal structures of tumor cells. The main type of neoplastic cell death during PDT with photoditazine is direct photocoagulation and ischemic necrosis of the tumor parenchyma due to the destruction of the neoplasm vascular bed. Today, considerable attention is paid to the development of other new PSS, namely, bacteriochlorophyll-α derivatives, which have an intense absorption of radiation in the long-wavelength region of the spectral range. These include the disulfide-bpi conjugate, which contains 2 molecules of dipropoxybacteriopurpurinimide and a cystamine residue, the results of which showed its high efficiency due to the destruction of the tumor vascular bed, the rapid slowdown and/or cessation of cell proliferative activity and their death by necrosis and apoptosis. Rapid progress in studying the mechanisms of action of PDt has shown that autophagy triggering using the lysosomal compartment to degrade and utilize damaged cell organelles and paraptosis associated with defective proteins in the endoplasmic reticulum also play an important role in the elimination of tumor cells. Conclusion. Apoptosis, autophagy, and paraptosis can occur after photodamage to mitochondria, lysosomes, or the endoplasmic reticulum. The balance of cell death pathways is often a determining factor in the effectiveness of PDT.
- 31 October 2022
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 21 (5) , 149-154
Open AccessForms of cell death and targets at photodynamic therapy
The aim of the study is to study the results of the most significant studies on the forms of tumor cell death and targets in photodynamic therapy (PDT). Material and methods. On the problem, we analyzed the Scopus, WoS, MedLine databases and found 31 sources. Results. PDT is an important tool for studying the pathways leading to the complete devitalization of a malignant tumor. Moreover, subcellular targets in pdt are determined by the properties of photosensitizers (PS). Particularly effective targets are lysosomes and mitochondria, including those for class I PS, photofrin. This explains the effectiveness of photofrin, although it has a weak absorption band in the region of 630 nm with a limited penetration depth into tissues. The development of new PSs with subcellular targets of photofrin, but with an absorption band in the long-wavelength region, is becoming very topical. Such FS are ideal for PDT. Second-generation PSS have already been introduced into clinical practice. The effectiveness of PDT with the use of photoditazine was shown. The mechanisms of action and targets of this PS have been established. The latter include the vessel wall, cytoplasmic membranes, and internal structures of tumor cells. The main type of neoplastic cell death during PDT with photoditazine is direct photocoagulation and ischemic necrosis of the tumor parenchyma due to the destruction of the neoplasm vascular bed. Today, considerable attention is paid to the development of other new PSS, namely, bacteriochlorophyll-α derivatives, which have an intense absorption of radiation in the long-wavelength region of the spectral range. These include the disulfide-bpi conjugate, which contains 2 molecules of dipropoxybacteriopurpurinimide and a cystamine residue, the results of which showed its high efficiency due to the destruction of the tumor vascular bed, the rapid slowdown and/or cessation of cell proliferative activity and their death by necrosis and apoptosis. Rapid progress in studying the mechanisms of action of PDt has shown that autophagy triggering using the lysosomal compartment to degrade and utilize damaged cell organelles and paraptosis associated with defective proteins in the endoplasmic reticulum also play an important role in the elimination of tumor cells. Conclusion. Apoptosis, autophagy, and paraptosis can occur after photodamage to mitochondria, lysosomes, or the endoplasmic reticulum. The balance of cell death pathways is often a determining factor in the effectiveness of PDT.
- Open Access
- 30 August 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (4) , 108-115
MOLECULAR IMAGING AND INTRAOPERATIVE RADIONAVIGATION IN PROSTATE CANCER
Introduction. Prostate cancer is one of the most common malignant neoplasms. Strategies to improve early diagnosis and subsequent therapy are being improved. An emphasis is placed on maintaining the quality of life and working capacity of patients after treatment. This can be achieved by improving methods of focal therapy, which depends on the accuracy of topical diagnosis and classification of the tumor. Hybrid molecular imaging (pet/ct and spect/ct) is used in addition to the methods of structural imaging (ultrasound, ct, mri). Intraoperative imaging using radionavigation systems is also used in open and endoscopic surgery for prostate cancer. Currently, it is a tool capable of reducing the invasiveness of surgery, localizing the area of metastatic lesions with a sensitivity and specificity of up to 95 %.Objective of the study: an overview of current and promising future methods of intraoperative radio navigation in the surgical treatment of prostate cancer.Material and methods. The review presents the methods of intraoperative radionavigation in the surgical treatment of prostate cancer. Radionavigation in the context of using tumarotropic radiopharmaceutical based on a prostate-specific membrane antigen, in which the drug accumulates in all tumor foci expressing this receptor, is also considered.Conclusion. The use of preoperative hybrid imaging and radio-guided surgery facilitate lesion identification and resection. Gamma probing allows detection of psma-positive tumor foci regardless of their depth. Fluorescence imaging methods (icg, photodynamic diagnostics, autofluorescence) are also used for intraoperative detection of pathological foci in real time. Multichannel gamma probing and cherenkov radiation detection, which combine the advantages of indirect and direct intraoperative imaging, have enormous potential.
- 30 August 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (4) , 108-115
Open AccessMOLECULAR IMAGING AND INTRAOPERATIVE RADIONAVIGATION IN PROSTATE CANCER
Introduction. Prostate cancer is one of the most common malignant neoplasms. Strategies to improve early diagnosis and subsequent therapy are being improved. An emphasis is placed on maintaining the quality of life and working capacity of patients after treatment. This can be achieved by improving methods of focal therapy, which depends on the accuracy of topical diagnosis and classification of the tumor. Hybrid molecular imaging (pet/ct and spect/ct) is used in addition to the methods of structural imaging (ultrasound, ct, mri). Intraoperative imaging using radionavigation systems is also used in open and endoscopic surgery for prostate cancer. Currently, it is a tool capable of reducing the invasiveness of surgery, localizing the area of metastatic lesions with a sensitivity and specificity of up to 95 %.Objective of the study: an overview of current and promising future methods of intraoperative radio navigation in the surgical treatment of prostate cancer.Material and methods. The review presents the methods of intraoperative radionavigation in the surgical treatment of prostate cancer. Radionavigation in the context of using tumarotropic radiopharmaceutical based on a prostate-specific membrane antigen, in which the drug accumulates in all tumor foci expressing this receptor, is also considered.Conclusion. The use of preoperative hybrid imaging and radio-guided surgery facilitate lesion identification and resection. Gamma probing allows detection of psma-positive tumor foci regardless of their depth. Fluorescence imaging methods (icg, photodynamic diagnostics, autofluorescence) are also used for intraoperative detection of pathological foci in real time. Multichannel gamma probing and cherenkov radiation detection, which combine the advantages of indirect and direct intraoperative imaging, have enormous potential.
- 24 September 2020
- Published by Publishing House Sreda in Development of education
- No. 3 (9),p. 107-114
Modern Opportunities of Using Blockchain Technology in the Education System
The article is devoted to the blockchain technology that that has been booming in recent years. The purpose of the article is to review the literature on the modern possibilities of using blockchain technology in the education system. A brief description of blockchain technology is given, modern directions for its development are put forward. The article analyzes the possibilities and prospects of using blockchain to solve some problems in the education system, describes the features and advantages of using blockchain technology in the field of education that are known today. The positive changes in the educational process, which may result from the use of this technology are defined. The article discusses the shortcomings and problems associated with the use of blockchain technology in education. Methods and materials: a systematic search of literature on Google Scholar databases was performed, works on the use of BT in education were reviewed, and materials on blockchain technology in education that are available on Research Gate were analyzed. The authors outline that most projects using the blockchain in education are under development. Currently, there is already data on the implementation of blockchain technology in the form of confirmation of the authenticity of documents on education, a student’s personal card, confirmation of accreditation of an educational organization and intellectual property, student identification. Results. 67 papers were identified in the Google Scholar database and 80 publications in the eLibrary database. A large number of online conversations on the topic under study were revealed, and 25 publications turned out to be full-text journal articles. The authors noted that every day there are new articles, reports about the organization of startups, the formation of research teams working to study the possibilities of using BT in the education system. Conclusions. The authors summarize the possibilities of using blockchain technologies in the field of education. The interdisciplinary approach and cooperation of educators with blockchain specialists will keep up with the booming digital technologies.
- 24 September 2020
- Published by Publishing House Sreda in Development of education
- No. 3 (9),p. 107-114
Modern Opportunities of Using Blockchain Technology in the Education System
The article is devoted to the blockchain technology that that has been booming in recent years. The purpose of the article is to review the literature on the modern possibilities of using blockchain technology in the education system. A brief description of blockchain technology is given, modern directions for its development are put forward. The article analyzes the possibilities and prospects of using blockchain to solve some problems in the education system, describes the features and advantages of using blockchain technology in the field of education that are known today. The positive changes in the educational process, which may result from the use of this technology are defined. The article discusses the shortcomings and problems associated with the use of blockchain technology in education. Methods and materials: a systematic search of literature on Google Scholar databases was performed, works on the use of BT in education were reviewed, and materials on blockchain technology in education that are available on Research Gate were analyzed. The authors outline that most projects using the blockchain in education are under development. Currently, there is already data on the implementation of blockchain technology in the form of confirmation of the authenticity of documents on education, a student’s personal card, confirmation of accreditation of an educational organization and intellectual property, student identification. Results. 67 papers were identified in the Google Scholar database and 80 publications in the eLibrary database. A large number of online conversations on the topic under study were revealed, and 25 publications turned out to be full-text journal articles. The authors noted that every day there are new articles, reports about the organization of startups, the formation of research teams working to study the possibilities of using BT in the education system. Conclusions. The authors summarize the possibilities of using blockchain technologies in the field of education. The interdisciplinary approach and cooperation of educators with blockchain specialists will keep up with the booming digital technologies.
- Open Access
- 30 August 2020
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 66 (2) , 24-32
IGG4-related diseases in endocrinology
Immunoglobulin-G4-related disease (IgG4-RD) is a chronic immunomediated pathology of different organs of local or systemic nature, which has been established as a separate clinical entity in the early 2000s and is characterized by storiform fibroid inflammation of the affected tissues, their increase, and elevated serum immunoglobulin-G4 (IgG4) levels. The most common manifestations of the disease are major salivary and lacrimal gland enlargement, lymphadenopathy and type 1 autoimmune pancreatitis (AIP1), however, other organs may be also involved (the thyroid, eyes, meninges, heart, lungs, kidneys, aorta, upper airways, mesentery, etc.). The effectiveness of treatment of IgG4-RD, as well as other pathological conditions, is also determined by the timely diagnosis. However, the latter is complicated due to the variety of clinical manifestations and rather variable diagnostic criteria. It is necessary to constantly update the evidence-based knowledge and diagnostic algorithms within this pathology in order to overcome the difficulties, and involve immunologists, endocrinologists, pathologists and specialists in other spheres. This review provides information about the etiology, pathogenesis, and current methods of diagnosis and treatment of IgG4-related diseases, as well as examples of some manifestations of IgG4-RD that an endocrinologist may face in practice.
- 30 August 2020
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 66 (2) , 24-32
Open AccessIGG4-related diseases in endocrinology
Immunoglobulin-G4-related disease (IgG4-RD) is a chronic immunomediated pathology of different organs of local or systemic nature, which has been established as a separate clinical entity in the early 2000s and is characterized by storiform fibroid inflammation of the affected tissues, their increase, and elevated serum immunoglobulin-G4 (IgG4) levels. The most common manifestations of the disease are major salivary and lacrimal gland enlargement, lymphadenopathy and type 1 autoimmune pancreatitis (AIP1), however, other organs may be also involved (the thyroid, eyes, meninges, heart, lungs, kidneys, aorta, upper airways, mesentery, etc.). The effectiveness of treatment of IgG4-RD, as well as other pathological conditions, is also determined by the timely diagnosis. However, the latter is complicated due to the variety of clinical manifestations and rather variable diagnostic criteria. It is necessary to constantly update the evidence-based knowledge and diagnostic algorithms within this pathology in order to overcome the difficulties, and involve immunologists, endocrinologists, pathologists and specialists in other spheres. This review provides information about the etiology, pathogenesis, and current methods of diagnosis and treatment of IgG4-related diseases, as well as examples of some manifestations of IgG4-RD that an endocrinologist may face in practice.
- Open Access
- 31 December 2019
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 13 (3) , 105-117
Interdisciplinary data bank in oncoendocrinology. Medullary thyroid cancer and type 2 multiple endocrine neoplasia syndromes
Medullary thyroid cancer (MTC) is about 5% of all thyroid carcinomas and is hereditary in 2030% of cases. Multiple endocrine neoplasia syndrome type 2 (MEN2), in addition to medullary thyroid cancer, may include pheochromocytoma, hyperparathyroidism, and some other manifestations. The multidisciplinary data bank (MDB) developed by us is a specialized resource for storing, accumulating and subsequent analysis of data on patients with MTC and MEN2 syndromes. The MDB allows you to collect data from any sources (primary care, medical institutions at various levels, federal centers) and provides internal automated control of the quality and quantity of input data. It is necessary to keep a record of such data to improve the efficiency of diagnostics, treatment and rehabilitation of patients. MDB is an integrated digital platform containing reference materials for doctors, which allows combining evidence-based clinical experience in patients, and provides the opportunity for expert support of medical decisions. In the long run, it will help us organize digitally stored data for machine learning and lays the groundwork for the development of artificial neural networks.
- 31 December 2019
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 13 (3) , 105-117
Open AccessInterdisciplinary data bank in oncoendocrinology. Medullary thyroid cancer and type 2 multiple endocrine neoplasia syndromes
Medullary thyroid cancer (MTC) is about 5% of all thyroid carcinomas and is hereditary in 2030% of cases. Multiple endocrine neoplasia syndrome type 2 (MEN2), in addition to medullary thyroid cancer, may include pheochromocytoma, hyperparathyroidism, and some other manifestations. The multidisciplinary data bank (MDB) developed by us is a specialized resource for storing, accumulating and subsequent analysis of data on patients with MTC and MEN2 syndromes. The MDB allows you to collect data from any sources (primary care, medical institutions at various levels, federal centers) and provides internal automated control of the quality and quantity of input data. It is necessary to keep a record of such data to improve the efficiency of diagnostics, treatment and rehabilitation of patients. MDB is an integrated digital platform containing reference materials for doctors, which allows combining evidence-based clinical experience in patients, and provides the opportunity for expert support of medical decisions. In the long run, it will help us organize digitally stored data for machine learning and lays the groundwork for the development of artificial neural networks.
- Open Access
- 10 July 2019
- Published by Russian Photodynamic Association in Biomedical Photonics
- Vol. 8 (2) , 25-30
Modern aspects of photodynamic therapy of actinic keratoses
Currently, photodynamic therapy (PDT) remains the most effective treatment for actinic keratosis (AK). With the increase in the incidence of AK, mainly due to the popularization of recreation in countries with increased insolation, there is an increasing interest in developing new methods of diagnostics and treatment and improving the existing ones. Studies that are aimed at determining the final efficacy of PDT, taking into account the resulting adverse reactions and long-term cosmetic results, are becoming increasingly popular. The nature of the light needed to excite a photosensitizer (PS) opens up new possibilities in the field of experimental studies that are aimed at reducing adverse reactions with similar efficacy of the applied therapy. In the review article, we presented the results of our own and foreign studies on the diagnosis and treatment of AK for 2017–2019, namely: we determined the possibilities of using sources with natural and short-wave radiation at different depths of skin lesions; presented a classification of the growth of AK in the basal layer of the epidermis, which increases the possibility of predicting the outcomes of the disease; showed the prevailing efficiency of fluorescent diagnostics compared with traditional diagnostic methods; evaluated the advantages of PDT using natural light and artificial sources of radiation; described the possibility of using a combination of drugs to increase the effectiveness of PDT in difficult to treat areas and in AK foci with a high degree of damage to the basal layer of the epidermis.
- 10 July 2019
- Published by Russian Photodynamic Association in Biomedical Photonics
- Vol. 8 (2) , 25-30
Open AccessModern aspects of photodynamic therapy of actinic keratoses
Currently, photodynamic therapy (PDT) remains the most effective treatment for actinic keratosis (AK). With the increase in the incidence of AK, mainly due to the popularization of recreation in countries with increased insolation, there is an increasing interest in developing new methods of diagnostics and treatment and improving the existing ones. Studies that are aimed at determining the final efficacy of PDT, taking into account the resulting adverse reactions and long-term cosmetic results, are becoming increasingly popular. The nature of the light needed to excite a photosensitizer (PS) opens up new possibilities in the field of experimental studies that are aimed at reducing adverse reactions with similar efficacy of the applied therapy. In the review article, we presented the results of our own and foreign studies on the diagnosis and treatment of AK for 2017–2019, namely: we determined the possibilities of using sources with natural and short-wave radiation at different depths of skin lesions; presented a classification of the growth of AK in the basal layer of the epidermis, which increases the possibility of predicting the outcomes of the disease; showed the prevailing efficiency of fluorescent diagnostics compared with traditional diagnostic methods; evaluated the advantages of PDT using natural light and artificial sources of radiation; described the possibility of using a combination of drugs to increase the effectiveness of PDT in difficult to treat areas and in AK foci with a high degree of damage to the basal layer of the epidermis.